News & Analysis on Clinical Trial Services & Contract Research And Development
ReSearch Pharmaceutical Services (RPS), a US based outsourcing company, has announced expansion plans in Latin America. This reflects the increasing trend of pharmaceutical companies exploiting the cost benefits associated with outsourcing their work...
Drug delivery specialist Iomai is testing a new flu vaccine which could make the use of needles unnecessary.
Tripos has announced the sale of its Discovery Informatics Business, as an initial step towards liquidation, in light of the current trend to low-cost Asian outsourcing.
BioProgress last week announced an update to their agreement with licensing partner FMC Corporation for its oral drug delivery technology, NRobe.
Angel Biotechnology this week announced a major development and GMP manufacturing deal with Danish biotech company CellCure.
A new syringe-testing rig has been launched by texture analysis equipment provider, Stable Micro Systems.
Biotech company Progen has decided to manufacture its new anti-cancer drug in-house rather than outsource it in order to save on costs after the FDA gave the thumbs up for the manufacture of the drug for its upcoming phase III clinical trial.